Know Cancer

or
forgot password

Prostate Cancer Risk Assessment Using Genetic Markers in General Practice


N/A
45 Years
80 Years
Open (Enrolling)
Male
Prostate Cancer

Thank you

Trial Information

Prostate Cancer Risk Assessment Using Genetic Markers in General Practice


Inclusion Criteria:



- patients who receive a PSA test

Exclusion Criteria:

- age over 80 years

- elevated PSA-level (> 4,0 ng/ml) concurrently or within previous 2 years

- prostate or bladder disease

- prostate cancer

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Screening

Outcome Measure:

Number of low risk patients who get a PSA test

Outcome Description:

The primary objective of this study is to evaluate the impact on use of PSA tests of introducing genetic PCa risk assessment in general practice.

Outcome Time Frame:

1 year, 2 years

Safety Issue:

No

Principal Investigator

Pia Kirkegaard, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

The Research Unit for General Practice, Aarhus University, Denmark

Authority:

Denmark: Danish Dataprotection Agency

Study ID:

2011-41-6904

NCT ID:

NCT01739062

Start Date:

February 2013

Completion Date:

June 2016

Related Keywords:

  • Prostate Cancer
  • PSA test
  • Prostate cancer
  • Genetic screening
  • Prostatic Neoplasms

Name

Location